RNA β€” AVIDITY BIOSCIENCES INC

Ownership history in STIFEL FINANCIAL CORP  Β·  5 quarters on record

This page tracks every 13F SEC filing in which STIFEL FINANCIAL CORP reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    RNA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 5 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 19,936 +5,220 +35.5% 0.00% $869K β€”
2025 Q2 ADDED 14,716 +88 +0.6% 0.00% $418K β€”
2025 Q1 ADDED 14,628 +7,679 +110.5% 0.00% $432K β€”
2024 Q4 REDUCED 6,949 -1,063 -13.3% 0.00% $202K β€”
2024 Q3 INITIATED 8,012 β€” β€” 0.00% $368K β€”

🏒 Other funds also holding RNA

As of 2025 Q4 β€” sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to STIFEL FINANCIAL CORP Holdings